Agilent Technologies to Acquire Biocare Medical for $950 Million to Strengthen Global Pathology Portfolio

Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit...

March 10, 2026 | Tuesday | News
BioMed Realty Signs 15-Year Lease with CordenPharma Colorado for Purpose-Built Lab Facility at Flatiron Park

BioMed Realty, the largest private owner and operator of real estate for the life science, technology and innovation industries, announced that CordenPha...

March 06, 2026 | Friday | News
ImmunoScape Advances Seed And Boost Cancer Therapy Programme With United States Clinical Collaboration

The company also announced a strategic investment from Leonardo DiCaprio ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures an...

March 06, 2026 | Friday | News
Biocytogen Secures $5 Million Milestone as IDEAYA Doses First Patient in Phase 1 Trial of Bispecific ADC IDE034

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as mono...

March 02, 2026 | Monday | News
Charles River Laboratories Raises 2026 Profit Forecast Following Strategic Asset Divestitures

Charles River Laboratories has raised its 2026 profit forecast following a strategic divestiture of non-core and underperforming assets, ...

February 27, 2026 | Friday | Analysis
Abbott Secures Shareholder Approval for Exact Sciences Acquisition in Major Diagnostics Expansion

Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests,  announced th...

February 24, 2026 | Tuesday | News
Sift Biosciences Raises $3.7M Pre-Seed Round to Advance AI-Driven Peptide Immunotherapy Platform

Pre-Seed Round Co-Led By Freeflow Ventures and Lifespan Vision Ventures With Participation From Valuence Ventures, Eisai Innovation, SBI US Gateway Fun...

February 20, 2026 | Friday | News
Bavarian Nordic Secures $22.5 Million Mpox and Smallpox Vaccine Order from Public Health Agency of Canada

Bavarian Nordic A/S  announced a new order valued at USD 22.5 million from the Public Health Agency of Canada (PHAC) for the Company’s mpox an...

February 19, 2026 | Thursday | News
Newron Pharmaceuticals S.p.A. Secures Up to €38 Million to Accelerate Phase III Evenamide Program in Treatment-Resistant Schizophrenia

Proceeds expected to fund global ENIGMA-TRS studies and extend cash runway beyond pivotal 12-week results, supporting development of evenamide as the p...

February 18, 2026 | Wednesday | News
Kevin Conroy Emphasizes Strong Momentum as Exact Sciences Corp. Reports 23% Q4 Revenue Growth and Expanding Oncology Portfolio

Total fourth quarter revenue of $878 million, an increase of 23% on a reported and core revenue basis, with Screening revenue of $695 million and Pre...

February 16, 2026 | Monday | Company results
Wellumio Raises $7.28 Million to Advance Portable MRI Technology for Rapid Stroke Diagnosis

Wellumio, a New Zealand-based medical technology company developing a portable neuroimaging device for rapid, point-of-care stroke detection, has raised $7...

February 12, 2026 | Thursday | News
Waters Expands into Global Diagnostics and Biosciences Powerhouse with BD Transaction Close

  Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-...

February 11, 2026 | Wednesday | News
Applied Medical Wins $381 Million Antitrust Verdict Against Medtronic

A team from Knobbe Martens obtained a decisive win for medical device manufacturer Applied Medical against Medtronic, Inc. in an antitrust case involving...

February 11, 2026 | Wednesday | News
Forma Life Sciences Established Following Acquisition of BioDuro’s California Manufacturing Assets

BioSelective Capital Investments and Shayan Enterprises, LLC, a Utah-based risk-capital investment firm,  announced the successful acquisition of Bi...

February 06, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close